Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitorsCharles G Caldwell, Ping Chen, Jiafang He, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitorsJennifer E Kowalchick, Barbara Leiting, KellyAnn D Pryor, et al.
Optics Express|May 5, 2017
Terahertz generation mechanism in nano-grating electrode photomixers on Fe-doped InGaAsPReshma A Mohandas, Joshua R Freeman, Michele Natrella, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Substituted piperazines as novel dipeptidyl peptidase IV inhibitorsLinda L Brockunier, Jiafang He, Lawrence F Colwell, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate)Dooseop Kim, Jennifer E Kowalchick, Scott D Edmondson, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
4-aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IVJoseph L Duffy, Brian A Kirk, Liping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Discovery of potent and selective beta-homophenylalanine based dipeptidyl peptidase IV inhibitorsJinyou Xu, Hyun O Ok, Edward J Gonzalez, et al.
BMC Health Services Research|August 16, 2017
Impact of inpatient Care in Emergency Department on outcomes: a quasi-experimental cohort studyAisha Lateef, Soo Hoon Lee, Dale Andrew Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2007
4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IVDavid E Kaelin, Abigail L Smenton, George J Eiermann, et al.
Cardiovascular Research|September 11, 2024
Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP miceMelanie Modder, Wietse In Het Panhuis, Mohan Li, et al.
Pageof 12